Adoptive Transfer of NK Cells Engineered with a SRCD5-Chimeric Antigen Receptor to Treat Invasive Fungal Infections
Por:
Velasco, M, Catal , C, Serradell, LC, Planells-Romeo, V, Arag n, L, Espa ol-Rego, M, P rez-Amill, L, Marco, F, Puerta-Alcalde, P, Garc a-Vidal, C, Mart n-Antonio, B and Lozano, F
Publicada:
10 nov 2025
Resumen:
Filiaciones:
Velasco, M:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Catal , C:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Serradell, LC:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Planells-Romeo, V:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Arag n, L:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Espa ol-Rego, M:
Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain
P rez-Amill, L:
Fundacio Clin Recerca Biomed, Barcelona, Spain
Marco, F:
Hosp Clin Barcelona, Serv Microbiol, Barcelona, Spain
:
Hosp Germans Trias I Pujol, Fundacio Lluita contra les Infecc, Barcelona, Spain
Garc a-Vidal, C:
Hosp Clin Barcelona, Serv Malalties Infeccioses, Barcelona, Spain
Mart n-Antonio, B:
Inst Salud Carlos III, Dept Dev Adv Therapy Med Prod, Madrid, Spain
Lozano, F:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain
Univ Barcelona, Barcelona, Spain
|